Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02316223 · ClinicalTrials.gov registry record · NA

Supporting Asthma Management Behaviors in Aging Adults

A NA study of Asthma, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
406
Enrollment target
3
Study locations

NCT02316223 is a NA study of Asthma that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 406 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (74% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02316223, a NA study of Asthma, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
406 participants
Enrollment target
3
Study locations

Study Summary

A 3-arm, patient-randomized trial among Latino and African-American older adults with poorly-controlled asthma will be conducted to compare the effectiveness of clinic-based vs. home-based asthma care coordination / self-management support (CC/SMS) vs. usual care.

Conditions Studied

Interventions

  • BEHAVIORAL Supporting Asthma Management Behaviors in Aging Adults (SAMBA)

Study Locations (3)

New York

  • The Institute for Family Health - New York
  • Mount Sinai-St. Luke's Roosevelt Hospital Center - New York
  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 406 participants
Start Date 2015-01
Est. Completion 2018-02-02
Phase NA

What the Registry Record Tells You About NCT02316223

The ClinicalTrials.gov registry entry for NCT02316223 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 406 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (74% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Supporting Asthma Management Behaviors in Aging Adults (SAMBA) is the first listed.

NCT02316223 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02316223 about?

NCT02316223 is a clinical study titled "Supporting Asthma Management Behaviors in Aging Adults". A 3-arm, patient-randomized trial among Latino and African-American older adults with poorly-controlled asthma will be conducted to compare the effectiveness of clinic-based vs. home-based asthma care coordination / self-management support (CC/SMS) vs. usual care.

What is the current status of trial NCT02316223?

This trial is currently completed. It is a NA study. The enrollment target is 406 participants. The study started on 2015-01. Estimated completion is 2018-02-02.

What conditions does trial NCT02316223 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT02316223?

The interventions under investigation include: Supporting Asthma Management Behaviors in Aging Adults (SAMBA) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02316223?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02316223 being conducted?

This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.